SAMBRIA-NeuroMed7 Clinic Presentation Deck.0714
Download as PPTX, PDF
0 likes198 views
Sambria Pharmaceuticals develops topical anesthetics like NeuroMed7 to reduce pain from medical procedures. NeuroMed7 combines lidocaine with absorption enhancers to work faster than other topical anesthetics. It aims to decrease wait times, increase daily procedures, and reduce costs for clinics while improving patient comfort through a non-prescription, easy to use product. Sambria believes NeuroMed7 offers clinics benefits like increased revenue, better control of anesthetic dosing, and decreased infection risks compared to multi-use products.
SAMBRIA-NeuroMed7 Clinic Presentation Deck.0714
- 1. SAMBRIA NeuroMed7 A Unique Approach In Topical Pain Management NeuroMed7速 TOPICAL ANESTHETIC The Comfort Cream!
- 2. Our Mission Sambria Pharmaceuticals develops safe and effective topical anesthetics: To decrease pre-procedural wait times To increase the volume of practice procedures per day To improve easy patient and clinician access to topical anesthetics To reduce topical anesthetic use cost per procedure To increase patient comfort and satisfaction
- 3. Our Approach Combine topical lidocaine with dermal absorption/penetration enhancers Reduce time to initial onset of action of topical anesthetics Improve procedural patient comfort in a cost-effective manner to clinicians Improve topical anesthetic ease of access to clinicians by providing an inventory storing capable, regulatory-compliant product that does not require prescription Provide a high-margin cash-and-carry product throughout the distribution channel
- 4. NeuroMed7速 Topical lidocaine HCL 4% with absorption/penetration enhancers Lidocaine HCl 4% in a topical cream formulation When used properly topical lidocaine HCl 4% has minimal, if any, negative systemic effect Single, sanitary one-use application packaging for clinical settings use Multi-dose packaging for in-office dispensing to patients for residual pain management as well as cost savings to clinic
- 5. NeuroMed7速 Used to reduce pain locally when applied externally directly to the skin. Desensitizes without causing profound, uncomfortable sensations on the skin. Free of counter irritants known to cause localized skin irritation. Free of topical acetaminophen, salicylates and other NSAIDs Non-prescription, easy clinic and patient access Clinician and patient friendly, affordable pricing By-pass the Reimbursement Maze
- 6. Topical Anesthetic Applications Can be used for: Minimally invasive procedures Aesthetic procedures LASER procedures Micro-needling Injections and venipuncture Discomfort management caused by cutaneous allergy reactions/inflammations, minor burns, lacerations and abrasions
- 7. Product differentiators Rapid onset of action Proprietary formula that includes dermal absorption/penetration enhancers Safe and effective concentration of topical anesthetic lidocaine HCl 4% Sanitary, single-use as well as multi-dose packaging Cost effective affordable price points throughout the distribution chain; from distributor to patient Non-prescription
- 8. Comparative Advantages Compared to EMLA, LMX and compounds, NeuroMed7速 is a small fraction of the cost Compared to EMLA, LMX and compounds NeuroMed速 takes a fraction of the time to initial onset of action Compared to EMLA, LMX and compounds your facility can save on cost while increasing number of procedures NeuroMed速 is non-prescription NeuroMed速 can be dispensed at high margins increasing practice revenue No gritty residue; single-use, sanitary, measured packaging for clinic use
- 9. Facility Benefits Decrease topical anesthetic cost per procedure Increase practice revenue by decreasing pre- procedural wait times (increase daily procedures volume) Non-prescription, in-office dispensing increases practice revenue (high retail margins) When used appropriately, single-use, sanitary packaging may decrease infection risk as compared to use of multi-use dispensed products Control anesthetic dosing by using measured, single-use packets (120 mgs lidocaine HCl per packet) Practice revenue source when multi-use tubes are offered to patients for residual pain
- 10. Facility Procurement and Margins Single-use, sanitary 3 ml packets - $1.99 each Box of 100 units is $199 Clinic Wholesale Acquisition Cost (WAC) - $20 per tube ($120 per box of 6 tube units) Retail dispensing MSRP $38.95 per 2.2 ounce tube Wholesale volume discounts available* * Minimum 12 tubes for discounts - 48 tubes for lowest clinic wholesale price per tube
- 11. Custom Label Program Sambria Pharmaceuticals provides white label manufacturing for select distributors Minimum white label order quantity is: 100 boxes of 100-units of single-use, sanitary packets and/or 500 individual 2.2 ounce, multi-use tubes White label manufacturing requirements include a minimum one-year agreement based on monthly minimum order volume White label requirements include mutual agreement for specified distribution channels (medical specialties and geographic regions) Distributor is required to market NeuroMed7 in accordance with all local, state and federal regulatory policies
- 12. Regulatory Compliance NeuroMed7 is manufactured, monitored and marketed in accordance with United States Food and Drug Administration (US FDA) regulations. Regulation policies are governed by the US FDA CFR 21 Monograph 348 OTC Topical Analgesic and Anesthetics. Monograph policy specifically directs marketers of medications in this category to list on its product packaging: topical analgesic, topical anesthetic, external analgesic, external anesthetic, or for the temporary relief of pain. *Monograph CFR 21 348.50(a) USA FDA NDC# 54723-175-22
- 14. Thank You!